

Page 39
conferenceseries
.com
Volume 2, Issue 2 (Suppl)
Optom open access
ISSN: 2476-2075 OMOA, an open access journal
Ophthalmologists 2017
September 25-26, 2017
September 25-26, 2017 Dubai, UAE
11
th
Global
Ophthalmologists Annual Meeting
Retinopathy of prematurity incidence, risk factors and treatment modalities among premature infants
at various neonatal intensive care units of central Karnataka in South India
Prakash V Suranagi, Ashutosh Patel, B S Prasad and Anand Vinekar
Thumbay Hospital , UAE
Statement of the Problem:
Retinopathy of prematurity (ROP) is a potentially blinding eye disorder of childhood that primarily
affects premature infants weighing 1250 grams or less/born before 31 weeks of gestation. ROP is a vaso-proliferative eye
disorder characterized by abnormal vascular development of retina. Various other risk factors also contribute. The purpose of
this study is to describe the incidence of ROP in various neonate intensive care units (NICU) and obtain information about
risk factors associated with ROP and treatment modalities.
Methodology &Theoretical Orientation:
Premature infant born at 36 weeks of gestation or younger or 2000 grams or smaller
were screened for ROP. 1350 babies were screened during October 2012 to March 2016. Screening was done with RETCAM
and indirect ophthalmoscope using 28D volk lenses under topical anesthesia and those requiring treatment were given laser
treatment. All the babies were followed up till 40 weeks of corrected gestation or until retina matured and further follow up
continued for those with ROP until resolved.
Findings:
In 1350 premature neonates, ROP was detected in 248 infants. Most of the babies were in the range of 26-34 weeks
of gestation age at birth. Total 74 infants had pre-threshold ROP, out of which 49 infants had Type-1 or high risk pre-threshold
ROP and were given laser treatment. Remaining 25 infants had type-2 or low risk pre threshold ROP and were followed weekly.
Conclusion & Significance:
ROP is one of the important causes of ocular morbidities and childhood blindness. The magnitude
of ROP in our study is 18.37%. Response to laser therapy is encouraging. Recommendation-Gestational age and low birth weight
were the most significant risk factors for development of ROP, thus screening those with more than 1.5 kg and gestational age
up to 36 weeks needs to be considered.
Biography
Prakash Suranagi has a passion and specializes for screening and management of neonates with Retinopathy of Prematurity (ROP). He has a Fellowship in
ROP from L V Prasad Eye Institute, Hyderabad, India (WHO collaborating center for prevention of blindness). He serves as Central Zone Karnataka Coordinator
(Technical) for Karnataka Internet Diagnosis of Retinopathy of Prematurity (KIDROP) under National Rural Health Mission (NRHM) of India and Narayana
Nethralaya Bangalore.
psuranagi@rediffmail.comPrakash V Suranagi et al., Optom open access 2017, 2:2 (Suppl)
DOI: 10.4172/2476-2075-C1-005